N@N

ASHP 2009 Research Award Presented to Research Team From the University of Michigan Health System

^{Published on 2009-12-03 06:55:51 - Market Wire}
 

TUCSON, AZ--(Marketwire - December 3, 2009) - CDEX Inc. (OTCBB: [ CEXI ]) ([ www.cdexinc.com ]) extends its congratulations to Dr. Jim Stevenson and members of his staff at the CS Mott Children's Hospital of the University of Michigan Health System, among the best in the nation, recipients of the 2009 ASHP Literature Award for Pharmacy Practice Research. Their study assessed the sensitivity and specificity of the ValiMed Medication Validation System (MVS) when used to confirm the admixture of high-risk parenteral medications. In the paper they also reported that in the first 18 months of use they identified five major medical errors that would have otherwise caused substantial harm to patients ([ http://www.cdexinc.com/pages/Stevenson_AJHP.pdf ]). Thanks to the courageous efforts of Dr. Stevenson and his staff, many Directors of Pharmacy around the world now better understand the reality that undetected, major errors in the compounding of high-risk medications are happening today in many hospitals and a technological safety net (such as the ValiMed MVS) is needed to protect patients.

CDEX will be demonstrating the lifesaving capabilities of the ValiMed MVS at the ASHP Mid-Year Conference (Venetian Hotel & Sands Expo Center) in Las Vegas on December 7-9, 2009. Dennis Quaid, representing the Dennis Quaid Foundation, will provide a keynote address at the Conference. CDEX invites all those interested in medication safety to stop by Booth # 743 and learn how ValiMed MVS is saving lives in major hospitals today.

About CDEX

CDEX develops, manufactures and globally distributes products to the healthcare and security markets. The ValiMed™ product line provides life-saving validation of high-risk medications and returned narcotics. The ID2™ product line detects trace amounts of illegal drugs, such as methamphetamine. CDEX expects to advance its patented technologies to serve additional markets. To meet its plans, CDEX must strengthen its financial position as stated periodically in its SEC filings. For more information, contact Malcolm Philips at [ mphilips@cdex-inc.com ].

Non-historical statements are forward-looking, as defined in federal securities laws, and generally can be identified by words such as "expects," "plans," "may," "believes," "should," "intends," and similar words. These statements pose risks that cannot be accurately predicted. Consequently, results may differ materially from those expressed or implied. Such risks and uncertainties include, without limitation, the effectiveness, profitability and marketability of products, the protection of intellectual property and proprietary information, and other risks detailed periodically in filings with the SEC. There is no obligation to update any forward-looking statements.